In another sign of the challenges facing gene therapy developers, Pfizer has abandoned its haemophilia B treatment Beqvez in all world markets, saying weak demand made the business non-viable. The ...

Novartis has reached an agreement to take control of Kate Therapeutics, a developer of gene therapies for inherited neuromuscular diseases, including Duchenne muscular dystrophy (DMD). The ...

Genes and Genetics News. Read today's medical research in genetics including what can damage genes, what can protect them, and more.

Selective targeting of genome amplifications and repeat elements by CRISPR-Cas9 nickases to promote cancer cell death Focal gene amplification is a common feature of advanced and metastatic cancers.